Skip to main content
SpringerLink
Log in

Human Immunodeficiency Virus/AIDS

  • Chapter
  • First Online:
Nutrition and Oral Medicine

Part of the book series: Nutrition and Health ((NH))

  • 2237 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Feller L, et al. Diffuse infiltrative CD8+ lymphocytosis syndrome: review of the literature and report of a case. SADJ. 2007;62(7):314–7.

    PubMed  CAS  Google Scholar 

  2. Glick M, et al. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol. 1994;77(4):344–9.

    Article  PubMed  CAS  Google Scholar 

  3. CDC. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993;41:1–10.

    Google Scholar 

  4. Moursi AM, et al. Nutrition and oral health considerations in children with special health care needs: implications for oral health care providers. Pediatr Dent. 2010;32(4):333–42.

    PubMed  Google Scholar 

  5. Colecraft E. HIV/AIDS: nutritional implications and impact on human development. Proc Nutr Soc. 2008;67(1):109–13.

    Article  PubMed  Google Scholar 

  6. Ahoua L, et al. Nutrition outcomes of HIV-infected malnourished adults treated with ready-to-use therapeutic food in sub-Saharan Africa: a longitudinal study. J Int AIDS Soc. 2011;14:2.

    Article  PubMed Central  PubMed  Google Scholar 

  7. McCullough M, et al. New approaches to Candida and oral mycotic infections: workshop 2A. Adv Dent Res. 2011;23(1):152–8.

    Article  PubMed  CAS  Google Scholar 

  8. Mehta S, et al. Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania. AIDS Patient Care STDS. 2011;25(10):579–85.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Grobler L, et al. Nutritional interventions for reducing morbidity and mortality in people with HIV. Cochrane Database of Systematic Reviews 2013, Issue 2. Art. No.: CD004536. DOI:10.1002/14651858.CD004536.pub3

  10. Sax PE, et al. Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States. PLoS ONE. 2012;7(2):e31591.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  11. CDC HIV in The United States: At a Glance http://www.cdc.gov/hiv/resources/factsheets/PDF/HIV_at_a_glance.pdf (2012). Accessed Aug 2012.

  12. Prejean J, et al. Estimated HIV incidence in the United States, 2006–2009. PLoS One. 2011;6(8):e17502.

    Google Scholar 

  13. Holloway IW, et al. Where are the young men in HIV prevention efforts? Comments on HIV prevention programs and research from young men who sex with men in Los Angeles county. J Prim Prev. 2012;33(5–6):271–8.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Slesak G, et al. High HIV vulnerability of ethnic minorities after a trans-Asian highway construction in remote northern Laos. Int J STD AIDS. 2012;23(8):570–5.

    Article  PubMed  CAS  Google Scholar 

  15. Nguyen HV, et al. The effect of participatory community communication on HIV preventive behaviors among ethnic minority youth in central Vietnam. BMC Public Health. 2012;12:170.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Llibre JM, Clotet B. Once-daily single-tablet regimens: a long and winding road to excellence in antiretroviral treatment. AIDS Rev. 2012;14(3):168–78.

    PubMed  Google Scholar 

  17. Hester EK. HIV medications: an update and review of metabolic complications. Nutr Clin Pract. 2012;27(1):51–64.

    Article  PubMed  Google Scholar 

  18. Fitch K, Grinspoon S. Nutritional and metabolic correlates of cardiovascular and bone disease in HIV-infected patients. Am J Clin Nutr. 2011;94(6):1721S–8S.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  19. Patton LL, et al. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89(3):299–304.

    Article  PubMed  CAS  Google Scholar 

  20. Greenspan D, et al. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet. 2001;357(9266):1411–2.

    Article  PubMed  CAS  Google Scholar 

  21. CDC. CDC Pneumocystis pneumonia: Los Angeles. MMWR. 1981;30:250.

    Google Scholar 

  22. Sullivan PS, et al. Prevalence of seroconversion symptoms and relationship to set-point viral load: findings from a subtype C epidemic, 1995–2009. AIDS 2012;26(2):175–84.

    Google Scholar 

  23. Roos MT, et al. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J Infect Dis. 1992;165(3):427–32.

    Article  PubMed  CAS  Google Scholar 

  24. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med. 1998;339(1):33–9.

    Article  PubMed  CAS  Google Scholar 

  25. Schacker T, et al. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med. 1996;125(4):257–64.

    Article  PubMed  CAS  Google Scholar 

  26. Greenspan JS, et al. Oral manifestations of HIV infection. Definitions, diagnostic criteria, and principles of therapy. The U.S.A. Oral AIDS Collaborative Group. Oral Surg Oral Med Oral Pathol. 1992;73(2):142–4.

    Google Scholar 

  27. EEC-Clearinghouse on oral problems related to HIV infection and WHO collaborating center on oral manifestations of the human immunodeficiency virus: an update of the classification and diagnostic criteria of oral lesions in HIV infection. J Oral Pathol Med. 1991;20:289–91.

    Google Scholar 

  28. Glick M, Siegel MA. Viral and fungal infections of the oral cavity in immunocompetent patients. Infect Dis Clin North Am. 1999;13(4):817–31 (vi).

    Google Scholar 

  29. Glick M. Clinical aspects of recurrent oral herpes simplex virus infection. Compend Contin Educ Dent. 2002;23(7 Suppl 2):4–8.

    PubMed  Google Scholar 

  30. Kademani D, Glick M. Oral ulcerations in individuals infected with human immunodeficiency virus: clinical presentations, diagnosis, management, and relevance to disease progression. Quintessence Int. 1998;29(8):523–34.

    PubMed  CAS  Google Scholar 

  31. Bergmann OJ, Mogensen SC, Ellegaard J. Herpes simplex virus and intraoral ulcers in immunocompromised patients with haematologic malignancies. Eur J Clin Microbiol Infect Dis. 1990;9(3):184–90.

    Article  PubMed  CAS  Google Scholar 

  32. Drew WL. Cytomegalovirus infection in patients with AIDS. J Infect Dis. 1988;158(2):449–56.

    Article  PubMed  CAS  Google Scholar 

  33. Mattes FM, et al. Histopathological detection of owl’s eye inclusions is still specific for cytomegalovirus in the era of human herpesviruses 6 and 7. J Clin Pathol. 2000;53(8):612–4.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  34. Spector SA, et al. Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS. J Virol. 1999;73(8):7027–30.

    PubMed Central  PubMed  CAS  Google Scholar 

  35. Syrjanen S, et al. Oral ulcers in AIDS patients frequently associated with cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections. J Oral Pathol Med. 1999;28(5):204–9.

    Article  PubMed  CAS  Google Scholar 

  36. Schrier RD, et al. Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC group. J Clin Invest. 1995;95(4):1741–6.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  37. Glick M, Berthold P. Oral manifestations of HIV infection. In Buckley RM, Gluckman SJ, editors. HIV infection in primary care. Philadelphia, PA: W. B. Saunders, 2002. p. 132–40.

    Google Scholar 

  38. Greenspan D, et al. Oral “hairy” leucoplakia in male homosexuals: evidence of association with both papillomavirus and a herpes-group virus. Lancet. 1984;2(8407):831–4.

    Article  PubMed  CAS  Google Scholar 

  39. Greenspan JS, et al. Replication of Epstein-Barr virus within the epithelial cells of oral “hairy” leukoplakia, an AIDS-associated lesion. N Engl J Med. 1985;313(25):1564–71.

    Article  PubMed  CAS  Google Scholar 

  40. Fisher DA, Daniels TE, Greenspan JS. Oral hairy leukoplakia unassociated with human immunodeficiency virus: pseudo oral hairy leukoplakia. J Am Acad Dermatol. 1992;27(2 Pt 1):257–8.

    Article  PubMed  CAS  Google Scholar 

  41. Epstein JB, Sherlock CH, Greenspan JS. Hairy leukoplakia-like lesions following bone-marrow transplantation. AIDS 1991;5(1):101–2.

    Google Scholar 

  42. Greenspan D, et al. Oral hairy leukoplakia in an HIV-negative renal transplant recipient. J Oral Pathol Med. 1989;18(1):32–4.

    Article  PubMed  CAS  Google Scholar 

  43. Greenspan JS, Greenspan D. Hairy leukoplakia and other oral features of HIV infection. Immunol Ser. 1989;44:449–65.

    PubMed  CAS  Google Scholar 

  44. Chang Y, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266(5192):1865–9.

    Article  PubMed  CAS  Google Scholar 

  45. O’Neill E, et al. Herpes virus-like sequences are specifically found in Kaposi sarcoma lesions. J Clin Pathol. 1996;49(4):306–8.

    Article  PubMed Central  PubMed  Google Scholar 

  46. Leao JC, Porter S, Scully C. Human herpesvirus 8 and oral health care: an update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(6):694–704.

    Article  PubMed  CAS  Google Scholar 

  47. Gorsky M, Epstein JB. A case series of acquired immunodeficiency syndrome patients with initial neoplastic diagnoses of intraoral Kaposi’s sarcoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(5):612–7.

    Article  PubMed  CAS  Google Scholar 

  48. Muzyka BC, Glick M. Sclerotherapy for the treatment of nodular intraoral Kaposi’s sarcoma in patients with AIDS. N Engl J Med. 1993;328(3):210–1.

    Article  PubMed  CAS  Google Scholar 

  49. Epstein JB, Scully C. HIV infection: clinical features and treatment of thirty-three homosexual men with Kaposi’s sarcoma. Oral Surg Oral Med Oral Pathol. 1991;71(1):38–41.

    Article  PubMed  CAS  Google Scholar 

  50. Epstein JB, et al. Oral Kaposi’s sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine. Cancer. 1989;64(12):2424–30.

    Article  PubMed  CAS  Google Scholar 

  51. Lusso P, et al. In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J Exp Med. 1988;167(5):1659–70.

    Article  PubMed  CAS  Google Scholar 

  52. Tyler KL. Emerging viral infections of the central nervous system: part 1. Arch Neurol. 2009;66(8):939–48.

    Article  PubMed Central  PubMed  Google Scholar 

  53. Theodore WH, et al. Human herpes virus 6B: a possible role in epilepsy? Epilepsia. 2008;49(11):1828–37.

    Article  PubMed Central  PubMed  Google Scholar 

  54. Lozada-Nur F, et al. Use of intralesional interferon-alpha for the treatment of recalcitrant oral warts in patients with AIDS: a report of 4 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92(6):617–22.

    Article  PubMed  CAS  Google Scholar 

  55. King MD, et al. Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection. Clin Infect Dis. 2002;34(5):641–8.

    Article  PubMed  Google Scholar 

  56. Gillison ML, et al. Prevalence of oral HPV infection in the United States, 2009–2010. JAMA. 2012;307(7):693–703.

    Article  PubMed  CAS  Google Scholar 

  57. D’Souza G, et al. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199(9):1263–9.

    Article  PubMed  Google Scholar 

  58. Beachler DC, et al. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev. 2010;21(1):122–33.

    Article  Google Scholar 

  59. Chaturvedi AK, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294–4230.

    Google Scholar 

  60. Campo J, et al. Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients. J Oral Pathol Med. 2002;31(1):5–10.

    Article  PubMed  CAS  Google Scholar 

  61. Patton LL. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(2):182–8.

    Article  PubMed  CAS  Google Scholar 

  62. MacPhail LA, et al. Differences in risk factors among clinical types of oral candidiasis in the Women’s Interagency HIV Study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(1):45–55.

    Article  PubMed  Google Scholar 

  63. Pienaar ED, Young T, Holmes H. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children. Cochrane Database Syst Rev. 2010;11:CD003940.

    Google Scholar 

  64. Phelan JA, et al. Oral candidiasis in HIV infection: predictive value and comparison of findings in injecting drug users and homosexual men. J Oral Pathol Med. 1997;26(5):237–43.

    Article  PubMed  CAS  Google Scholar 

  65. Rhodus NL. Treatment of oral candidiasis. Northwest Dent. 2012;91(2):32–3.

    PubMed  Google Scholar 

  66. Bensadoun RJ, et al. Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011. Support Care Cancer. 2011;19(6):737–44.

    Article  PubMed  Google Scholar 

  67. Park KK, Brodell RT, Helms SE. Angular cheilitis, part 1: local etiologies. Cutis. 2011;87(6):289–95.

    PubMed  Google Scholar 

  68. Gonsalves WC, Chi AC, Neville BW. Common oral lesions: part I. Superficial mucosal lesions. Am Fam Physician. 2007;75(4):501–7.

    PubMed  Google Scholar 

  69. Park KK, Brodell RT, Helms SE. Angular cheilitis, part 2: nutritional, systemic, and drug-related causes and treatment. Cutis. 2011;88(1):27–32.

    PubMed  Google Scholar 

  70. Ng KH, Siar CH. Review of oral histoplasmosis in Malaysians. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81(3):303–7.

    Article  PubMed  CAS  Google Scholar 

  71. Warnakulasuriya KA, et al. Localised oral histoplasmosis lesions associated with HIV infection. J Oral Pathol Med. 1997;26(6):294–6.

    Article  PubMed  CAS  Google Scholar 

  72. Economopoulou P, Laskaris G, Kittas C. Oral histoplasmosis as an indicator of HIV infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;86(2):203–6.

    Article  PubMed  CAS  Google Scholar 

  73. Glick M, et al. Necrotizing ulcerative periodontitis: a marker for immune deterioration and a predictor for the diagnosis of AIDS. J Periodontol. 1994;65(5):393–7.

    Article  PubMed  CAS  Google Scholar 

  74. Lucht E, Heimdahl A, Nord CE. Periodontal disease in HIV-infected patients in relation to lymphocyte subsets and specific micro-organisms. J Clin Periodontol. 1991;18(4):252–6.

    Article  PubMed  CAS  Google Scholar 

  75. Robinson PG. Which periodontal changes are associated with HIV infection? J Clin Periodontol. 1998;25(4):278–85.

    Article  PubMed  CAS  Google Scholar 

  76. Narani N, Epstein JB. Classifications of oral lesions in HIV infection. J Clin Periodontol. 2001;28(2):137–45.

    Article  PubMed  CAS  Google Scholar 

  77. Winkler JR, Robertson PB. Periodontal disease associated with HIV infection. Oral Surg Oral Med Oral Pathol. 1992;73(2):145–50.

    Article  PubMed  CAS  Google Scholar 

  78. Muzyka BC, Glick M. HIV infection and necrotizing stomatitis. Gen Dent. 1994;42(1):66–8.

    PubMed  CAS  Google Scholar 

  79. Ship JA, et al. Recurrent aphthous stomatitis. Quintessence Int. 2000;31(2):95–112.

    PubMed  CAS  Google Scholar 

  80. Muzyka BC, Glick M. Major aphthous ulcers in patients with HIV disease. Oral Surg Oral Med Oral Pathol. 1994;77(2):116–20.

    Article  PubMed  CAS  Google Scholar 

  81. Ship JA. Recurrent aphthous stomatitis. An update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81(2):141–7.

    Article  PubMed  CAS  Google Scholar 

  82. Weidle PJ. Thalidomide for aphthous ulcers in patients infected with the human immunodeficiency virus. Am J Health Syst Pharm. 1996;53(4): 368, 371–372, 378.

    Google Scholar 

  83. Kerr AR, Ship JA. Management strategies for HIV-associated aphthous stomatitis. Am J Clin Dermatol. 2003;4(10):669–80.

    Article  PubMed  Google Scholar 

  84. Tirelli U, Franceschi S, Carbone A. Malignant tumours in patients with HIV infection. BMJ 1994;308(6937):1148–53.

    Google Scholar 

  85. Tirelli U, et al. Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy. AIDS 2000;14(12):1675–88.

    Article  PubMed  CAS  Google Scholar 

  86. Lozada-Nur F, et al. Intraoral non-Hodgkin’s lymphoma in seven patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;82(2):173–8.

    Article  PubMed  CAS  Google Scholar 

  87. Epstein JB. Oral malignancies associated with HIV. J Can Dent Assoc. 2007;73(10):953–6.

    PubMed  Google Scholar 

  88. Epstein JB, Huhmann MB. Dietary and nutritional needs of patients undergoing therapy for head and neck cancer. J Am Dent Assoc. 2011;142(10):1163–7.

    Article  PubMed  Google Scholar 

  89. Epstein JB, Huhmann MB. Dietary and nutritional needs of patients after therapy for head and neck cancer. J Am Dent Assoc. 2012;143(6):588–92.

    Article  PubMed  Google Scholar 

  90. Chainani-Wu N, Epstein J, Touger-Decker R. Diet and prevention of oral cancer: strategies for clinical practice. J Am Dent Assoc. 2011;142(2):166–9.

    Article  PubMed  Google Scholar 

  91. Forrester JE, Sztam KA. Micronutrients in HIV/AIDS: is there evidence to change the WHO 2003 recommendations? Am J Clin Nutr. 2011;94(6):1683S–9S.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  92. WHO: Nutrient requirements for people living with HIV/AIDS: report of a technical consultation, World Health Organization, Geneva, 13–15 May 2003. http://www.who.int/nutrition/publications/Content_nutrient_requirements.pdf. Accessed Aug 2012.

  93. Chlebowski RT, et al. Dietary intake and counseling, weight maintenance, and the course of HIV infection. J Am Diet Assoc. 1995;95(4):428–35.

    Google Scholar 

  94. Fitch KV, et al. Effects of a lifestyle modification program in HIV-infected individuals with the metabolic syndrome. AIDS 2006;20:1843–50.

    Google Scholar 

  95. Rabeneck L, et al. A randomized controlled trial evaluating nutrition counseling with or without oral supplementation in malnourished HIV-infected patients. J Am Diet Assoc. 1998;98:434–8.

    Article  PubMed  CAS  Google Scholar 

  96. Schwenk A, Steuck H, Kremer G. Oral supplements as adjunctive treatment to nutritional counseling in malnourished HIV-infected patients: randomized controlled trial. Clin Nutr. 1999;18(6):371–4.

    Google Scholar 

  97. Tabi M, Vogel RL. Nutritional counselling: an intervention for HIV-positive patients. J Adv Nurs. 2006; 54(6): p. 676–82.

    Google Scholar 

  98. Topping CM, et al. A community-based, interagency approach by dietitians to provide meals, medical nutrition therapy, and education to clients with HIV/AIDS. J Am Diet Assoc. 1995;96:683–68.

    Article  Google Scholar 

  99. Academy of Nutrition and Dietetics: HIV/AIDS Nutrition Evidence Analysis Project. 2010. (cited January 8, 2012); Available from: http://andevidencelibrary.com/topic.cfm?cat=4248.

  100. Adeyemi OM, et al. Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. J Acquir Immune Defic Syndr. 2011;57(3):197–204.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  101. Sroussi HY, et al. Association among vitamin D, oral candidiasis, and calprotectinemia in HIV. J Dent Res. 2012;91(7):666–70.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oral Medicine and Diagnostic Sciences, UIC College of Dentistry (MC 838), 801 S. Paulina St., Room 528, Chicago, IL, 60612, USA

    Herve Y. Sroussi

  2. Department of Pediatric Dentistry, UIC COD (MC 850), 801 S. Paulina St., Room 563A, Chicago, IL, 60612, USA

    Linda M. Kaste

  3. Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA

    Joel B. Epstein

  4. Division of Otolaryngology and Head and Neck Surgery, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA, 91010, USA

    Joel B. Epstein

  5. Department of Nutritional Sciences—School of Health Related Professions, Rutgers University Biomedical and Health Sciences (formerly University of Medicine and Dentistry of New Jersey), 65 Bergen St Rm 156, Newark, NJ, 07107-3001, USA

    Pamela Rothpletz-Puglia

Authors
  1. Herve Y. Sroussi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Linda M. Kaste
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joel B. Epstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pamela Rothpletz-Puglia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Herve Y. Sroussi .

Editor information

Editors and Affiliations

  1. Department of Nutritional Sciences, School of Health Related Professions, Division of Nutrition, Rutgers School of Dental Medicine, Rutgers, The State University, Newark, New Jersey, USA

    Riva Touger-Decker

  2. University of Nevada, Las Vegas School of Dental Medicine, Las Vegas, Nevada, USA

    Connie Mobley

  3. City of Hope National Medical Center, Duarte, California, USA

    Joel B. Epstein

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sroussi, H.Y., Kaste, L.M., Epstein, J.B., Rothpletz-Puglia, P. (2014). Human Immunodeficiency Virus/AIDS. In: Touger-Decker, R., Mobley, C., Epstein, J. (eds) Nutrition and Oral Medicine. Nutrition and Health. Humana Press, New York, NY. https://doi.org/10.1007/978-1-60761-490-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-490-6_14

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-60761-489-0

  • Online ISBN: 978-1-60761-490-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation